Objectives-The purpose of this study was to perform an updated analysis of complications associated with upper and lower extremity peripheral nerve blocks (PNBs) performed with ultrasound (US) guidance versus the landmark approach.
clinical trials suggested the superiority of ultrasound (US) guidance compared to electrical peripheral nerve stimulation (PNS); a 2009 meta-analysis underscored that with this new technology, nerve block success is enhanced; anesthetic onset is hastened; the block duration is increased; and needle-blood vessel encounters are markedly reduced. 2 Subsequently, several large database studies provided evidence that local anesthetic systemic toxicity (LAST) is reduced with the use of US guidance. 3, 4 However, the impact of US on nerve-related complications has been less clear. 5 Our own preliminary report described outcomes at our institution as we gradually moved from the use of PNS for principal needle guidance to the predominant use of US imaging over a 6-year period. 6 Over the subsequent 4 years, we completed the transition to the use of US for all PNBs in our orthopedic ambulatory anesthesia practice. Although the prior report noted a significant decline in LAST as we moved to the newer form of guidance, 6 in this study, we sought to substantiate that the benefits noted previously continue to enhance safety for our patients. The objective of our report is to summarize our data regarding LAST as well as other nerve block-related complications for the past 4-year period, as well as analyze the impact of US on these parameters over the entire 10-year evolution from the primary use of PNS until the time of complete implementation of US for guidance of PNB. We hypothesize that implementation of US to replace landmark PNS guidance has resulted in significantly fewer LAST complications in our practice.
Materials and Methods

Study Design
We performed a single-center retrospective cohort analysis of patients who underwent PNB for surgery and postoperative analgesia before or after an orthopedic procedure involving an upper or lower extremity. The patients were assessed with regard to the type of guidance for the nerve block: those primarily guided by a US-based approach, with or without concomitant use of PNS, or those guided by PNS and anatomic landmarks. The primary outcome measure was the occurrence of LAST, whereas secondary outcomes included both short-and long-term nerve injury, infection at the block site, hematoma, pneumothorax, and unintended neuraxial blockade. The review was performed with an exempt status granted by the University of Pittsburgh Institutional Review Board.
Data Collection
The analysis was performed by using deidentified data obtained from our departmental prospective quality improvement/patient safety database. The database serves as a standard record of complications related to anesthesia care at all hospitals in the University of Pittsburgh Medical Center health system. It is maintained prospectively and continuously updated by anesthesiologists, nurse anesthetists, as well as perioperative nurses and contains all suspected adverse events, including those related to PNBs, at the time of their discovery. Specified instances of nerve block complications pursued by our anesthesiology and perioperative team for potential inclusion in the database are broad and include instances of LAST, sensory or motor deficits, pneumothorax, block site hematoma or infection, and unintended neuraxial blockade. These events are periodically peer reviewed and selectively brought up for discussion at patient safety meetings when a substantial deviation from the standard of care is suspected. Sentinel and serious events are also reported to the state Department of Health.
Although some nerve block complications, such as LAST, are detected at the time of or shortly after the performance of the block, a separate clinical pathway outlined in our previous report 7, 8 was used to evaluate potential nerve injuries resulting in motor or sensory dysfunction subsequent to resolution of nerve blockade. All patients receive a routine follow-up call within 2 days after surgery to establish the duration of the nerve block. If the patient reports continuing weakness or numbness within the appropriate nerve distribution, the patient is contacted again later until symptoms resolve. In addition, all surgical offices are also educated and encouraged to contact the Department of Anesthesiology if there is a concern for nerve dysfunction in the postoperative period. Cases with persistent dysfunction are promptly referred to a designated physiatrist specializing in chronic pain and nerve injury. The subsequent formal evaluation may include nerve conduction studies and electromyography when indicated.
For this report, we performed a combined 10-year analysis of the quality improvement database covering the period between January 1, 2006, through December 31, 2015. This review specifically focused on all instances of new nerve block complications over 48 months starting from January 1, 2012, which immediately followed the time frame of our previous analysis 6 as well as all cases of short-term nerve injuries for the entire 10-year period that had not been reported by our group previously.
All instances of reported complications were extracted and included in this report. Particular attention was given to the cases of LAST and suspected nerve injury. The statistical analysis was only limited to upper and lower extremity blocks performed for orthopedic procedures. Truncal blocks, such as paravertebral, which comprise only a small proportion at our facility, were excluded. In addition, blocks that were performed solely by using the landmark approach alone without US or PNS were also excluded (eg, ankle block and subcutaneous saphenous block).
To quantify the rate of complications, adverse events (and, in particular, cases of LAST) were grouped according to the technique used and were tallied together, similar to our prior analysis. 6, 7 This total served as a "numerator" for our calculations. In addition, to obtain the total number of blocks performed during this study period, we used our department's billing database. This total served as our "denominator" in the calculation of complication rates. It was also used as a source of additional details such as the type of nerve block performed and to provide a month-to-month breakdown of US-PNS vs landmark-PNS use in our facility. All data was de-identified at the time of acquisition to comply with the IRB exempt status rules. In order to visualize our group's ongoing transition to US-guided techniques for all PNBs, we also extended our billing query of the month-to-month block data back to 2010.
Patient Cohorts
We grouped our patients into 2 cohorts. The US-PNS cohort included all patients whose blocks were performed by using US guidance either with or without PNS. The nerve stimulator, in conjunction with US, is used at times for confirmation of the identity of the nerve to be blocked and for excluding intraneural needle tip placement, which is seen with very low stimulation thresholds. In contrast to the landmark approach, in these cases it is not used in our practice to establish the needle-nerve proximity. The second cohort, landmark-PNS, included all patients who underwent PNBs performed with the nerve stimulator as the primary localization tool, along with a physical assessment of anatomic landmarks.
We did not stratify the patients according to whether the block was done as a "single shot" or "continuous infusion." The basic principle of nerve localization between the two types of blocks was the same, and the bolus dose did not change in our practice regardless of whether the patient would be receiving continuous infusion postoperatively. However, in the results of this report, we clearly indicated which PNBs were performed as a continuous infusion.
Primary and Secondary Outcomes
As noted above, our primary outcome measure was the occurrence of LAST. Secondary outcomes included nerve injury, unintended neuraxial blockade, infection, pneumothorax, substantial local tissue injury, and hematoma.
Consistent with our prior reports, 6, 7 LAST was defined as an instance of either central nervous system of cardiovascular toxicity. Our department chose to focus on central nervous system toxicity, defined as generalized seizure with the tonic-clonic motion of the patient accompanied by loss of consciousness within 60 minutes of PNB. Milder forms of such a brief episode of confusion could not be effectively captured in the perioperative setting and are likely underrepresented in the quality improvement database. The latter instances were thus not included in this analysis.
Cases of cardiovascular toxicity would have to manifest as hypotension requiring inotropic or vasopressor support, ventricular dysrhythmia, or cardiac arrest during or after PNB but before induction of anesthesia.
Our criteria for inclusion of a condition as a neural complication rested primarily on the patient's symptoms, including reports of sensory loss, painful tingling or dysesthesia, or loss of motor function. Although referrals for neurologic evaluations and electrodiagnostic studies were made for those with persistent symptoms, many patients with more evanescent conditions had resolution before this process was accomplished. In all instances, evidence of electromyography or a nerve conduction defect was not a requirement.
Cases of nerve injuries marked for inclusion as PNB complications were defined as sensory or motor deficits within the appropriate nerve distribution and not clearly attributed to other causes. These were subdivided into short-term, lasting between 7 days and 6 months, and long-term, subdivided into persistent deficits of a 6-to 12-month duration, as well as those that lasted beyond 12 months.
Statistical Analysis
For representation purposes, the calculated incidence of PNB complications was expressed as a number per 1000 blocks. We estimated 95% confidence intervals (CIs) using the binomial (Clopper-Pearson) "exact" method. The statistical analysis comparing the incidences of LAST and long-term nerve injuries between the US-PNS and landmark-PNS techniques was performed by a v 2 test with Yates correction given a low incidence of these events. A comparative analysis of the short-term nerve injury rates was performed by a v 2 test without Yates correction given their larger count. P < .05 was chosen as a threshold for statistical significance, in consideration with the CIs as noted above.
We calculated the number needed to treat to prevent an instance of LAST with the US-guided technique based on the 95% CI of the absolute risk reduction using the incidence of seizures in the patient cohorts. Finally, we also estimated the loss to follow-up in our study by quantifying the success rate of reaching our patients in the postoperative period to assess the resolution of nerve blockade. No sample size calculation was performed before this study, since the main goal was to present a consecutive review of a complications database in a manner following our previous investigation.
Details of Nerve Block Procedures
All nerve blocks at our institutions are performed in a preoperative holding area. Most patients receive fentanyl, are versed for mild sedation for procedures, or both, with the primary goal of achieving anxiolysis, and all maintain a conversant status. The patients are also continuously monitored by pulse oximetry and noninvasive blood pressure measurements during and after the procedure.
Almost all blocks performed at our institution are conducted by supervised anesthesiology residents (postgraduate levels 2-4). In this review, we only noted whether the proceduralist was a resident or attending anesthesiologist in cases of block complications. We did not track the resident's level of experience or the total number of procedures performed by attending anesthesiologists versus trainees.
In any given case, the decision to perform the block using US-PNS or landmark-PNS was up to the attending anesthesiologist assigned to the case. Historically, a decision about which method would be used was made before meeting the patient and, typically, was performed in concert with the resident to expand the resident's experience with peripheral nerve techniques. There was no effort to perform any specific nerve blocks exclusively using one or the other technique. No randomization between the techniques occurred. Lately, however, as our practice has shifted primarily to the US-PNS technique, the teaching of landmark-PNS blocks has been deemphasized, and all blocks are currently provided with US guidance. In any case, the reason to choose the specific technique was not consistently documented in our records and could not be extracted for our analysis. In our current practice, all blocks, whether PNS is used, are performed with stimulating needles (Stimuplex; B. Braun USA, Bethlehem, PA; or SonoPlex; Pajunk Medical Systems, Norcross, GA). Continuous nerve blocks are now performed with a catheter over a needle system (E-Cath; Pajunk Medical Systems).
When the PNS-landmark technique was used, the stimulator (B. Braun USA) was initially set at 0.8 to 1.0 mA, with a frequency of 2 Hz and a pulse duration of 0.1 milliseconds. The needle was then advanced until stimulation continued to elicit an appropriate motor response with current decreased to 0.25 to 0.5 mA before injection of the local anesthetic was performed.
For US-guided blocks, our current practice uses a bedside US unit (S-Nerve; SonoSite, Inc, Bothell, WA) with a 6-13-MHz linear transducer or, occasionally, a 2-5-MHz curvilinear transducer for larger patients in cases of deep PNBs such as transgluteal or subgluteal sciatic. All blocks are performed by an in-plane needle visualization technique. The color Doppler mode is frequently adopted to assess for vascular structures near the nerve fascicles before introduction of the needle. The needle is advanced until the tip is nearly in contact with the nerve, typically in a tangential fashion, and injection is performed in a "paraneural fashion" with the goal of circumferentially surrounding nerve structures with the local anesthetic. The use of PNS for secondary confirmation of nerve identification and to exclude intraneural needle placement before injection is at the discretion of the attending anesthesiologist, in which case the needle is advanced until the needle tip proximity to the nerve is evident, followed by turning on PNS to establish the threshold of stimulation. If this stimulation is less than 0.3 mA, suggesting the tip may be within the epineurium of the nerve, the needle tip is pulled back until a higher threshold is noted before injection of the local anesthetic solution.
All injections are performed in small aliquots of 2.5 to 5 mL with aspiration tests in between. With US-PNS blocks, we aim to achieve visual tissue expansion with each injection of solution. The block needle is slightly withdrawn in cases in which "excessive" resistance to injection is felt or if the injection appears "intraneural," manifested as nerve expansion during injection in cases in which US is used.
The local anesthetic mixture and its concentration for the block solution have undergone several iterations in our department over the course of the previous 10 years, but the general principles remain the same. The most substantial change from our previous analysis is the substitution of bupivacaine for ropivacaine in our blocks, which occurred during a period of ropivacaine unavailability in April 2013. Subsequently, we were pleased with the duration of bupivacaine blocks and continue to use this drug, albeit at a lower concentration than had been previously used with ropivacaine.
We have developed and consolidated several clinical pathways for upper and lower extremity nerve blocks. Currently, we use bupivacaine 0.5% for interscalene blocks and a mixture of mepivacaine 0.2% and bupivacaine 1.2% for axillary, supraclavicular, and popliteal-sciatic blocks. A mixture of mepivacaine and bupivacaine is specifically used for interscalene blocks in patients with sleep apnea to allow the earlier return of diaphragmatic function. This population comprises approximately 9% of our patients. Femoral and sciatic nerve blocks are performed with bupivacaine 0.125% alone as analgesic blocks at the request of the orthopedists because of recent revelations in the Sports Medicine literature concerning postoperative muscle atrophy, particularly of the quadriceps.
Our practice has generally been very conservative with the use of additives. Clonidine was previously included in some of the PNB injections but is currently no longer used, given the longer duration of bupivacaine. We have also avoided using such adjuncts as corticosteroids, epinephrine, and dexmedetomidine.
Results
During the period from January 1, 2012, through December 31, 2015, we performed 8287 PNBs using either the US-PNS or landmark-PNS technique. Nearly 94% of these blocks were performed with US guidance, with or without the adjunctive use of PNS (Table 1) . A detailed month-to-month representation of US use can be seen in Figure 1 . The most rapid decline in the landmark-PNS technique use appeared to have been completed in the period immediately preceding our current query. Within the calendar year 2015, less than 3% of blocks were performed by the landmark-PNS approach.
During this 4-year period, there were 3 cases of suspected nerve injury manifesting as sensory deficits lasting more than 6 months after femoral and interscalene blocks (Table 1) . Nonanesthetic causes of these deficits have been excluded. All cases occurred within the US-PNS group. Two of the patients refused further workup, and their deficits resolved within 1 year. In the remaining case, in which numbness of the thumb persisted beyond 12 months after an interscalene block, a nerve conduction test revealed no detectable abnormalities. There were no reported cases of sensory or motor deficits Nerve Injury 6-12 mo, n (95% CI/1,000 blocks) 0 (0-7/1,000) 2 (0.03-0.9/1,000) P 5.7 Nerve Injury > 12 mo, n (95% CI/1,000 blocks) 0 (0-7/1,000) 1 (0.003-0.7/1,000) P 5.8 LAST, n (95% CI/1,000 blocks) 1 (0.05-10/1,000) 0 (0-0.5/1,000) P 5.06
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following landmark-PNS blocks within the current study period.
Our current query also revealed 1 case of LAST presenting as a generalized tonic-clonic seizure during an interscalene block using the landmark-PNS technique (Tables 1 and 2 ). The seizure immediately followed local anesthetic injection and was thus attributed to unintended intravascular injection into the vertebral artery or another small vessel. Blocks performed with the US-PNS technique had no recognized cases of LAST, and there were no cases of cardiovascular toxicity with either technique within this period.
In all instances of nerve complications and LAST, the blocks were performed by residents who were directly supervised by attending anesthesiologists. Beyond cases of LAST and peripheral neurologic deficits, we also uncovered 1 instance of localized erythema around a femoral nerve catheter, which resolved shortly after its discontinuation. This condition may have represented localized infection, although the patient reported pruritus at the site with no pain and no exudate or discharge. During this period, there were no recognized cases of pneumothorax, bleeding, hematomas, or unintended neuraxial blockade. The statistical analysis for the current 4-year period did not show a significant difference in the incidence of suspected nerve injuries lasting more than 6 months (US-PNS, 2 of 7789; versus landmark-PNS, 0 of 498; P 5 .7) or 1 year (US-PNS, 1 of 7789; versus landmark-PNS, 0 of 498; P 5 .8) between the cohorts. The incidence of LAST was similarly not statistically different (US-PNS, 0 of 7789; versus landmark-PNS, 1 of 498; P 5 .06; Table 1 ).
Our previous quality improvement database queries uncovered 4 additional cases of sensorineural deficits lasting between 6 and 12 months after PNB, all occurring in the landmark-PNS group between January 1, 2006, and December 31, 2011. In 3 additional instances, the patients continued to report persistent symptoms beyond 1 year. There were also 6 additional cases of LAST, all occurring in the landmark-PNS cohort, within this period. There was also 1 additional case of nerve injury lasting beyond 6 months but resolving by 1 year in the US-PNS group. No additional cases of LAST were uncovered by our previous queries in the US-PNS cohort.
On combining the data over the entire 10-year period of transition from the primary landmark to US guidance, 16,858 blocks were performed by the US-PNS technique and 5934 by the landmark-PNS technique. The statistical analysis comparing the incidence of nerve injury between the techniques again failed to reveal a significant difference in deficits lasting between 6 and 12 months (US-PNS, 3 of 16,858; versus landmark-PNS, 4 of 5934; P 5 .1) or beyond 1 year (US-PNS, 1 of 16,858; versus landmark-PNS, 3 of 5934; P 5 .1).
With regard to short-term nerve injury, lasting at least 7 days but resolving before 6 months, our combined 10-year query revealed 63 additional injuries: 30 of 16,858 in the US-PNS cohort and 33 of 5934 in the landmark-PNS cohort (Table 3 ). This difference in the incidence of these injuries between the cohorts was found to be statistically significant (P < .0001). The statistical significance was also retained when all instances of nerve injuries, including short and long term, were combined: 34 of 16,858 in the US-PNS cohort versus 40 of 5934 in the landmark-PNS cohort (P < .0001; Table 3 ).
With regard to the incidence of LAST over the entire 10-year span, the occurrence in PNBs performed by the landmark-PNS technique was significantly higher than for US-PNS blocks (US-PNS, 0 of 16,858 versus landmark-PNS, 7 of 5934; P < .0001). The risk reduction for LAST when performing blocks using US-PNS instead of landmark-PNS corresponds to an estimated number needed to treat of 800 with a 95% CI spanning 500 to 3000.
A quantitative breakdown of all suspected nerve injuries by block type is presented in Table 4 . Although the incidence of suspected peripheral neurologic injuries appeared to be higher for femoral, sciatic, and popliteal fossa-sciatic nerve blocks, neither of the block types was Nerve Injury 6-12 mo, n (95% CI/1,000 blocks) 4 (0.2-2/1,000) 3 (0.04-0.5/1,000) P 5.1 Nerve Injury > 12 mo, n (95% CI/1,000 blocks) 3 (0.1-1/1,000) 1 (0.002-0.3/1,000) P 5.1 All nerve injuries, n (95% CI/1,000 blocks) 40 (5-9/1,000) 34 (1-3/1,000) P <.0001 a LAST, n (95% CI/1,000 blocks) 7 (0.5-2/1,000) 0 (0-0.2/1,000) P <.0001 (NNT 95% CI, 500-3,000) overrepresented in the landmark-PNS cohort (Table 3) . Similarly, although the cases of LAST most commonly occurred during or after interscalene blocks (5 of 7) using the landmark-PNS approach (Table 2) , the number of interscalene blocks performed was not overrepresented in this cohort.
Patient demographics, comorbidities, and details of procedures for patients with complications are summarized in Tables 2 and 5 , respectively. We estimate that the loss to follow-up in our study was less than 7% based on our success rate of reaching our patients individually for a phone interview in the postoperative period.
Discussion
In this update of our database study, we recount the transition of a regional anesthesiology service from one that relied primarily on PNS coupled with palpation of physical landmarks as a guidance mechanism to one that now uses US imaging for needle localization of all PNBs. This perspective is unique for a study of PNB outcomes, capturing the significant fall in LAST as one method replaced the other to the point that this potentially lifethreatening form of toxicity appears to have been virtually eradicated in our practice.
The impact of our adoption of US guidance on postoperative nerve-related conditions is less clear. Although transient neurologic complications appeared to be somewhat lessened when US was used for guidance, the long-term complications, including those lasting between 6 and 12 months as well as deficits persisting beyond 12 months, which were far less numerous, were not different between the cohorts. Of note, the etiology of many transient neurologic complications is especially difficult to differentiate from other causes in this setting, which include surgical injury, effects of postoperative edema, and temporary limb immobilization. In addition, given the minor nature of these deficits, their rapid improvement, or both, the implication of our findings is not immediately clear.
Our anesthesiology division, as for many physician practices, has undergone change over time. New, younger providers have been added, and several older physicians have retired in the 10-year span on which we based this study. Older providers had a higher propensity to use nerve stimulation for needle guidance and not US, whereas younger providers arrive with strong US experience and use this modality exclusively to perform PNB. Indeed, this evolution in physician makeup of the practice is an important reason for complete integration of US as the primary guidance method for our nerve blocks.
Ultrasound confers many benefits in procedural guidance and specifically in PNB. These include the ability to visualize the US anatomy underlying the transducer, including both normal and anomalous structures, 9, 10 and the ability to visualize the needle as it is directed toward the nerves, either directly or through a variety of potential image enhancement techniques.
11
In addition, imaging of the disposition of the injectate and its physical relationship with the nerve is invaluable, allowing the anesthesiologist to take advantage of fascial planes or sheaths that contain or channel the local anesthetic solution to optimize the success and speed of nerve blockade. 12, 13 Notably, imaging of vessels during real-time imaging reduces the likelihood of encountering these vessels during the block procedure. 2 In some cases, blocks that were considered risky or dangerous before US guidance, such as the supraclavicular brachial plexus block, are now performed quite frequently, with a marked reduction in adverse patient outcomes.
14 Terrifying "never events," such as spinal cord injury during 
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interscalene brachial plexus blockade, appear to have become actual never events with the use of US for guidance. The improvements in patient outcomes regarding LAST may stem from several different attributes of US guidance. As noted, the ability to avoid blood vessels is an obvious advantage. The operator can also observe for "spread" of injected fluid within the tissues at the tip of the needle, which should always be apparent so that, in its absence, one must cease injecting until intravascular needle tip placement is excluded as a possibility. In some peripheral blocks, the change in the trajectory of needle insertion to facilitate imaging of the needle, as in an interscalene block, reduces the chance of encountering deep arteries or veins (e.g. the vertebral vessels). 15 In addition, the required doses of the local anesthetic required for many blocks have been substantially reduced, consistent with the improved accuracy of the technique. 16 No longer do anesthesiologists require "volume blocks" with greater than 40 mL of a local anesthetic solution injected into tissue planes or potential spaces in the hopes of bathing multiple nerves. Higher success rates 2 also reduce the need for "reblocks," which necessitate patient exposure to higher dosages, increasing the potential for toxicity.
The consequences of LAST may be profound and life threatening. Minor symptoms and signs resulting from relatively modest elevations in blood levels of local anesthetic drugs include perioral numbness, a metallic taste in the mouth, and visible twitching. As blood levels increase, more concerning manifestations will occur, such as muscle twitching and tremors involving the facial musculature or distal extremities. 17 When severely toxic levels of these drugs reach the brain, generalized tonicclonic seizures occur, 17, 18 which may be brief and selflimited or require active management with benzodiazepines. In some cases, rapid loss of consciousness without seizure manifestations may occur. 18 Of greater concern, cardiovascular toxicity may occur as blood levels rise. These are usually, but not always, preceded by central nervous system manifestations. 18 Cardiac toxicity is most prevalent with the higher-potency, long-acting, lipid-soluble amide local anesthetics bupivacaine and ropivacaine. These agents affect conduction, inotropy, and oxidative phosphorylation in the heart and may cause ventricular dysrhythmias, profound hypotension, or cardiac arrest. 18 Toxicity from these agents, by virtue of their avid tissue binding in the heart, is also difficult to treat. The introduction of an intravenous lipid emulsion, described by Weinberg et al 19 in 2003 in animal studies, has revolutionized the management of LAST.
Several large database studies have provided solid evidence that LAST is reduced with US guidance for nerve blockade. Sites reporting on a quality assurance database from Dartmouth University in 2012 noted only 1 occurrence of LAST in more than 12,000 US-guided regional anesthesia cases. 3 Although that work was not a comparative study, prior estimates of expected LAST in training programs suggested that it would occur in 1 per 1000 to 1 per 2000 cases, 20 so it appeared that the prevalence with US guidance was markedly lower than with older techniques. Indeed, the improvement in the incidence of LAST may be most notable in training facilities: our database reflects blocks provided by supervised trainees in greater than 95% of cases.
In a multicenter study from 20 sites in Australia and New Zealand, Barrington and Kluger 4 reported on more than 20,000 PNBs, approximately two-thirds of which were conducted with US. The authors demonstrated a significant reduction of LAST when US was used, with a risk ratio of 0.25 to 0.33. Liu et al 21 reported on the conduct of more than 80,000 PNBs at the Hospital for Special Surgery in New York City, with greater than 90% of blocks conducted with US guidance by the end of the reporting period. 21 There were only 3 episodes of LAST, manifesting as seizures. Although the American Society of Regional Anesthesia and Pain Medicine acknowledged that US guidance "may be helpful" to avoid toxicity in 2010, the recommendation for inclusion of US guidance in 2016 was much stronger. 22 Despite these favorable reports, however, the potential for LAST remains as long as local anesthetic drugs are injected into patients, and the necessity to maintain vigilance remains. Ironically, as the threat of such severe adverse reactions is reduced, our capacity to manage them effectively may likewise be dwindling, as noted by Weinberg and Barron. 23 One might also predict that, along with toxic systemic reactions, local injuries to nerves might also be substantially reduced when US is used for guidance during PNBs. However, the literature on this aspect is not nearly as persuasive, and large-scale studies comparing needle guidance modalities are rare. Fredrickson and Kilfoyle 24 evaluated patients in the postoperative period in more than 1000 US-guided blocks and reported neurologic disturbances in greater than 8% of them (mostly transient numbness episodes), a rate quite consistent with reports from the pre-US era. An early comparison of US versus nerve stimulation guidance for interscalene blocks revealed no substantial difference in reported sensory disturbances in the postoperative phase, up to 6 weeks after surgery. 5 However, the same group of authors, reporting on a much larger number of cases derived from a database at their institution a year later, noted a rate of postoperative neurologic disturbances that was less than 10% of what had been noted in the smaller study. 25 Furthermore, in a prospective observational study of US-guided interscalene blocks with low volumes (in comparison to the pre-US era), Rajpal et al 26 noted a rate of sensory disturbances that was considerably lower than those reported in the nerve stimulation period and consistent with the lower rate reported by Liu et al. 25, 27 It may be that, as time allows for refinement of US techniques and improved US platforms with higher degrees of visual refinement, we will be able to show consistent improvements in neurologic outcomes. Conversely, if a substantial proportion of reported symptoms are related to the local anesthetic drugs themselves, or if the neurologic dysfunction is related to factors other than the block (eg, surgery, inflammation, and immobilization), then it is unlikely that any difference will be detectable. As with this study, the prevailing literature does not provide firm evidence for the superiority of US guidance in this regard.
Several limitations of this study merit consideration. Retrospective database reviews, by their very nature, are less detailed in outcomes analysis than prospective comparative studies. Although the inclusion of cases in the database was prospective, the query of the database for study purposes was necessarily retrospective, precluding inquiries for aspects of care that were not specified for collection. However, we believe that our primary outcome, severe LAST manifesting as seizure or cardiovascular toxicity, was completely captured by our quality improvement mechanism and represents the most relevant "hard" outcome for clinical purposes. However, minor episodes of toxicity, such as perioral numbness or tremor, however, might not be reported in the database if self-limited and not progressive. We believe that the clinical importance of such minor events is unlikely to be high.
It is well known that adverse occurrences related to nerve dysfunction are not as readily detected as seizure or cardiac toxicity, since they typically occur in the aftermath of surgery and sometimes do not manifest until days later. We have implemented a thorough follow-up system that is successful at capturing greater than 93.5% of our patients within the first 3 postoperative days, when callbacks are provided. In addition, we have established close clinical relationships with all of our orthopedic surgeons, who promptly notify our department and refer all patients with ongoing neurologic concerns for further follow-up. Although sensory concerns are usually evanescent and may not be reported by patients, we are confident that any case of substantial motor loss or functional impairment would be captured either by our team or by the orthopedic surgeon during the follow-up phase.
Finally, it is acknowledged that some of our providers still use PNS, even with US guidance for PNB. However, as described above, this use of nerve stimulation is not for localization of the nerve, as it is in the landmark-PNS technique, but rather to identify specific nerves during the block by their motor response or to reduce the possibility of intraneural needle tip placement, which may manifest as very low stimulation thresholds. 28 Since it is not being used as a guidance technique, we believe that this use of PNS in association with US guidance does not constitute a confounder or an "overlap" with the landmark-PNS approach, in which the stimulator is clearly being used to localize the nerve.
In conclusion, our anesthesiology group, which provides frequent PNBs for painful orthopedic surgery, has integrated US as the means of guidance for these procedures over a 10-year period. Our quality improvement database reflects a significant reduction of LAST episodes during this time frame, consistent with several other studies, which is most likely attributable to the use of US imaging during needle placement and injection. However, the impact of this technology at this point in time has not resulted in a significant reduction in reported long-term postoperative neurologic dysfunction.
